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Introduction
HIV, the causative agent of AIDS, is severely species restricted, 
and, to date, only humans and chimpanzees have been shown to 
be susceptible to infection (1, 2). The limited species specificity of 
HIV represents a significant challenge for in vivo experimentation, 
thus the use of animal models for infection has become increas-
ingly important. Human infection by HIV (and infection by its rel-
ative SIV in nonhuman primates) is restricted to cells expressing 
the CD4 molecule. In addition to CD4, productive HIV infection, 
meaning infection that leads to the production of viral progeny, 
requires one of two different G protein–coupled receptors: CCR5 
or CXCR4 (3). CD4+ T cells have been shown to harbor HIV provi-
ruses and represent the most abundant target for HIV infection in 
vivo (4, 5). Despite the prevalence of virus in CD4+ T cells, it is clear 
that T cells are not the only targets of HIV infection. In fact, macro-
phages have been shown to express CD4, CCR5, and CXCR4 and 
to be susceptible to HIV and SIV infection in vitro and in vivo (6–8). 
Nonhuman primates and humanized mice have been extensively 
used to study HIV and SIV infection and pathogenesis in vivo. HIV 
or SIV infection of macrophages and microglia, the tissue-resident 
macrophages of the brain, are postulated to substantially contrib-
ute to the establishment and pathogenesis of HIV or SIV infection 
in the CNS (9–11). The CNS is a location that has been considered 
to be a sanctuary for the virus, where variants of HIV can replicate 
and expand independently of contributions from the periphery (12, 
13). It has been suggested that the compartmentalization between 
the blood and CNS is associated with the ability of HIV variants 
in the CNS to infect cells, such as macrophages, with lower lev-
els of CD4 (14). This is especially problematic in the brain, where 
resident macrophages, such as microglia and perivascular macro-
phages, could then be susceptible to infection (9).
Analysis of monocytes from peripheral blood consistently 
shows very low levels or an outright lack of infection in viremic or 
aviremic patients (15–17). Evidence of both in vitro virus outgrowth 
from human monocytes obtained from patients and ex vivo virus 
outgrowth from tissue macrophages (including the brain or CNS) 
is also limited. Whereas the ability of HIV to replicate in human 
macrophages in vitro has been extensively documented, evidence 
for HIV replication in human macrophages in vivo is limited and, 
in some instances, indirect (18–20). Analysis of the gut has yielded 
somewhat conflicting results, as human intestinal macrophages 
did not support HIV replication ex vivo and were found to be more 
monocyte-like in receptor expression patterns (20); yet, viral HIV 
DNA was isolated from CD13+ cells sorted from rectal biopsies 
obtained from antiretroviral therapy–suppressed (ART-suppressed) 
patients, suggesting a non–T cell origin (21). However, the presence 
of HIV- or SIV-infected macrophages in a variety of tissues has been 
clearly documented using IHC and ISH approaches (8, 22–24).
In vivo macrophage infection is currently a topic of intense 
debate. Specifically, data from Calantone et al. suggest that in 
SIV-infected nonhuman primates, myeloid cells are not a major 
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cells that can support replication in these mice are of myeloid ori-
gin, we have designated these as myeloid-only mice (MoM). HIV 
infection of MoM with select isolates resulted in robust and sus-
tained replication. HIV DNA and/or RNA were found in virtually 
all tissues analyzed, including the brain. Replication-competent 
virus could be recovered from tissue macrophages, and the trans-
fer of infected macrophages into uninfected animals resulted in 
sustained infection. Our results also demonstrate the ability of 
human macrophages to fully sustain HIV infection and replication 
in vivo in the complete absence of human T cells, confirming the 
role of macrophages as genuine targets for HIV infection in vivo.
Results
Absence of HIV in peripheral blood monocytes isolated from viremic 
patients or from patients undergoing ART. To determine the fre-
quency of HIV infection in peripheral blood monocytes in 
humans, we collected samples from 8 patients (see Table 1 for 
patients’ demographic information). Four of these patients were 
receiving ART and four were not. We then used a multistep proto-
col for the purification and enrichment of monocytes and T cells 
using magnetic beads (Figure 1A). Specifically, mononuclear cells 
(MNCs) were first isolated using Ficoll gradient centrifugation. 
Human T cells were removed from the MNC preparations using 
a CD3-specific reagent via positive magnetic selection. After T 
cell removal, blood monocytes were isolated using a negative 
selection approach that again removed any residual T cells. This 
procedure yielded highly purified preparations of monocytes for 
analysis (Figure 1B). Whole blood cells, purified monocytes, and 
enriched T cells were analyzed for the presence of HIV-gag DNA 
using nested PCR analysis. Clear evidence of HIV DNA was 
detected in purified T cell preparations in samples obtained from 
infected patients, regardless of their treatment status (Figure 1C). 
No evidence of vDNA was observed in any of the analyzed purified 
monocyte preparations from these same patients (limit of detec-
tion was 2 DNA copies).
To address the frequency at which replication-compe-
tent HIV isolates exist in the blood monocytes of HIV-infected 
patients, we evaluated virus outgrowth from peripheral blood–
derived monocytes and T cells isolated from nonsuppressed HIV- 
infected patients injected i.v. into BLT mice. Using patients’ puri-
fied peripheral blood cells (patients 01–03 in Table 1 and Figure 
source of virus (25). Rather, macrophages ingest T cells, which 
explains the presence of HIV nucleic acids and proteins in mac-
rophage preparations. Further evidence in support of this postu-
late has also been recently presented by Baxter et al. (26). In this 
article, the authors document that human monocyte–derived 
macrophages (MDMs) selectively capture and engulf HIV- 
infected human T cells and that detection of viral DNA (vDNA) or 
viral proteins within phagocytes, including macrophages, may not 
necessarily represent their infection, but may indicate uptake of 
infected immune cells or their debris (26). However, these authors 
indicate that uptake of virus by phagocytosis could potentially 
lead to infection of macrophages. Together, these results strongly 
suggest that analysis of HIV replication in macrophages in vivo is 
greatly compromised by the extensive presence of T cells. In addi-
tion to being significantly more abundant, T cells are also more 
susceptible to HIV and SIV infection than are macrophages via 
cell-free or cell-associated virus (26, 27).
In order to establish the susceptibility of human myeloid cells 
to HIV and their ability to sustain HIV replication and productive 
infection in vivo, we first determined the incidence of HIV infec-
tion in peripheral blood monocytes from viremic and suppressed 
HIV-infected patients. Our analysis demonstrated that, in con-
trast to the relative abundance of HIV DNA found in T cells, we 
were unable to detect HIV DNA in peripheral blood monocytes. 
Analysis of primary tissue macrophages from humans remains 
difficult, as these samples are not easily accessible, being tissue 
derived, and viability can suffer as a consequence of handling. 
Invasive techniques such as bronchoscopy or biopsy are necessary 
to acquire the samples (28), and it is difficult to expand these cells 
ex vivo. While blood monocytes can be differentiated in vitro into 
macrophages, these cells lose much of their heterogeneity that 
results from anatomical location, which is critical in mimicking 
primary tissue macrophages (29, 30). Because of the difficulties 
associated with using primary tissue macrophages from humans, 
we used a humanized mouse model, in which the only human cells 
present capable of supporting HIV replication are human myeloid 
cells (31–33). NOD/SCID mice transplanted with human CD34+ 
(hCD34+) stem cells are reconstituted with human myeloid and 
B cells and are completely devoid of human T cells. Our analysis 
of internal organs demonstrated the presence of human macro-
phages in all tissues analyzed including the brain. Since the only 
Table 1. Characteristics of HIV-1–infected patients
Patient no. ART treatment Plasma viral load (copies/ml) CD4 count CD4/CD8 ratio Sex Age (yr)
01 No 4,300 208 0.15 F 41
02 No 109,910 118 0.30 M 57
03 No 30,730 264 0.86 M 24
04 No 10,816 589 0.90 M 29
05 Yes <40 1278 0.70 F 51
06 Yes <40 424 0.94 M 54
07 Yes <40 282 0.74 M 43
08 Yes <40 585 1.04 M 27
No, indicates not currently on any ART (no exclusion if previously treated); Yes, indicates currently suppressed on ART; M, male; F, Female; CD4/CD8 ratio, 
percentage of CD4+ T cells in peripheral blood divided by the percentage of CD8+ T cells in peripheral blood by flow cytometry.
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Reconstitution of NOD/SCID mice with hCD34+ hematopoietic 
stem cells results in systemic reconstitution with myeloid cells and an 
absence of T cells. In order to establish whether tissue macrophages 
are infected in vivo, we used an in vivo mouse model designed for 
this purpose. Preconditioned NOD/SCID mice were administered 
a bone marrow transplant consisting of hCD34+ cells (31–33) and 
monitored for up to 7 months for human reconstitution as deter-
mined by the presence of human cells in peripheral blood (n = 52). 
Over time, human hematopoietic cells (CD45+) in the peripheral 
blood of these mice increased in numbers that remained stable 
after approximately 8 to 12 weeks and persisted throughout the 
duration of the experiments (Figure 2A). Lineage analysis of the 
human cells present in the peripheral blood of these mice clearly 
1C), purified monocytes and T cells were injected into BLT mice. 
After 2 to 8 weeks, mice were harvested and cells from the differ-
ent tissues of BLT mice were analyzed for the presence of HIV 
DNA using nested PCR (Figure 1D). Consistent with the lack of 
HIV DNA monocytes (Figure 1C), we did not observe outgrowth 
in any of the BLT mice that received patients’ purified monocytes.
In contrast, we found replication-competent virus in all BLT 
mice that received purified T cells. This in vivo outgrowth assay 
demonstrates the absence of replication-competent virus in 
monocytes obtained from the peripheral blood of HIV-infected 
patients. These results further highlight the importance of an 
animal model in which analysis of tissue macrophages can be 
readily accomplished.
Figure 1. Absence of HIV DNA in monocytes but not in T cells isolated from peripheral blood of infected patients. (A) Schematic of monocyte and T cell 
purification strategy. Total MNCs were isolated from the peripheral blood of 8 HIV-infected patients (from Table 1). T cells were depleted using positive 
magnetic selection, and monocytes were enriched using negative magnetic selection. (B) Flow cytometric analysis of total MNCs, T cells, non–T cells, non-
monocytes, and monocytes revealed very pure populations of both T cells and monocytes isolated using this protocol (data from patient 04 are shown). 
(C) One million purified T cells or monocytes (Mono) were analyzed for the presence or absence of HIV-gag DNA using nested PCR analysis of untreated 
and treated patients. The lower limit of detection for these analyses was 2 copies of HIV DNA. Purified T cells or monocytes from untreated patients 01, 
02, and 03 were injected into BLT mice. (D) vDNA analysis demonstrated systemic infection of BLT mice injected with patients’ purified T cells but not 
monocytes. LN, lymph node; Org, human thymic organoid; Pt, patient.
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of classical (CD14+CD16–) and intermediate (CD14+CD16+) mono-
cyte and macrophage subsets (34, 35), with the classical pheno-
type representing the majority of the monocytes and macrophages 
present in these mice (Figure 2D), as is also observed in humans 
(36). Additionally, the majority of these cells expressed MHC class 
II, as denoted by expression of HLA-DR (Figure 2D). These results 
demonstrate the systemic repopulation of these mice with human 
myeloid cells and B cells in the complete absence of human T cells.
Reconstitution with human cells observed in the brains of NOD/
SCID mice transplanted with CD34+ cells. HIV infection of the brain 
and its sequela are hallmarks of AIDS. Macrophages have been 
indicated the presence of human B and myeloid cells (Figure 2, B 
and C). No evidence of human T cells in the peripheral blood of 
these mice was noted at any time during the experiment.
Analysis of the cells present in tissues obtained from trans-
planted mice confirmed their systemic reconstitution with human 
hematopoietic cells (Figure 2, B and C). Lineage analysis of the 
cells present in bone marrow, liver, lung, and spleen demonstrated 
the presence of human B and myeloid cells. We consistently failed 
to find T cells in any of the tissues analyzed (Figure 2B). Analysis 
of hCD14 and hCD16 expression on the cells present in the periph-
eral blood and tissues of these mice demonstrated the presence 
Figure 2. NOD/SCID mice transplanted with hCD34+ hematopoietic stem cells are reconstituted with human B cells and myeloid cells but lack T cells. 
(A) Flow cytometric analysis of the peripheral blood of mice showed a sustained presence of 20% to 30% hCD45+ cells over time (28 weeks shown, n = 
52). (B) Flow cytometric analysis of the bone marrow, spleen, liver, lung, and peripheral blood of a representative mouse demonstrated the presence of 
human B cells (hCD19+) and human myeloid cells (hCD33+), with a complete absence of human T cells (hCD3+). (C) Average levels of human cell reconsti-
tution in bone marrow (n = 36), spleen (n = 36), liver (n = 35), lung (n = 35), and peripheral blood (n = 18) and the distribution between myeloid and B cells 
of the human cells. (D) Phenotypic characterization of the human monocytes and macrophages in the tissues of a mouse reconstituted with hCD34+ cells 
(gating scheme: live → hCD45+ → hCD33+/hCD11b+). (E) Flow cytometric analysis of the brains of MoM demonstrated the presence of human B cells and 
macrophages, with a lack of human T cells. Percentages in B, D, and E signify the percentage of cells expressing the indicated surface markers for the cell 
populations designated in the gating strategy. PB, peripheral blood.
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(46); and 1 HIV-1 macrophage-tropic virus (ADA) (47). All viruses 
utilize CCR5 as a coreceptor for infection (46, 48, 49). In addition, 
we also evaluated a chimeric virus derived from CH040, in which 
we replaced its envelope gene with one obtained from the cere-
brospinal fluid (CSF) of a patient with moderate CNS disease; this 
envelope was previously characterized as being macrophage-tropic 
(Subject #4013, Envelope #C7, denoted as CH040-4013 env) (12). 
BLT mice and ToM were infected via multiple routes, and viral rep-
lication was monitored weekly or biweekly in plasma via viral load 
analysis as previously described (39, 41, 50–53). All viruses tested, 
without exception, efficiently replicated in vivo in both BLT mice 
and ToM (Figure 3, A and B). Each of these viruses maintained 
detectable levels of viral replication in the plasma of all exposed 
animals. These results confirm the in vivo replication competence 
of all viruses used in this study.
Replication of HIV in NOD/SCID mice transplanted with CD34+ 
cells is strictly limited to macrophage-tropic viruses. To investigate 
HIV infection of myeloid cells in vivo, we used NOD/SCID mice 
reconstituted with CD34+ cells that therefore lacked human T 
cells. Mice were exposed to a single i.v. dose of the HIV isolates 
evaluated above in BLT mice and ToM. Virus replication was 
monitored weekly for up to 15 weeks as a function of plasma viral 
load as previously described (41, 50–53). We found no evidence of 
HIV-1 or HIV-2 replication in any of the mice infected with JRCSF, 
THRO, RHPA, CH058, or 7312A (Figure 3C). Evidence of HIV 
replication, as determined by the presence of viral RNA (vRNA) 
in plasma, was observed in CD34+ cell–reconstituted NOD/SCID 
mice exposed to ADA, CH040, and CH040-4013 env only (Fig-
ure 3C). All of the viruses that were capable of replicating in mice 
shown to be important targets of SIV and HIV infection in the brain 
(10, 11, 23). Therefore, we investigated the presence of human cells 
in the brains of reconstituted mice. To minimize potential contami-
nation from cells in the blood in the brain, animals were transcardi-
ally perfused with PBS at necropsy. Brain tissue was used to isolate 
MNCs via Percoll density centrifugation, and isolated cells were 
analyzed via flow cytometry. Human B cells and macrophages were 
found in the brains of all mice, and there was no evidence of human 
T cells in any of the brains analyzed (Figure 2E). Similar to the rest 
of the tissues analyzed in the previous experiment, macrophages 
isolated from the brains of these mice had both classical and inter-
mediate phenotypes as determined by CD14 and CD16 expression 
levels. These results demonstrate reconstitution of the brains of 
these NOD/SCID mice with human hematopoietic cells.
Analysis of infection by a diverse set of HIV isolates in humanized 
bone marrow/liver/thymus mice and T cell–only mice demonstrates 
the ability of these isolates to efficiently replicate in vivo. To establish 
the fitness of each HIV isolate prior to evaluation of replication in 
macrophages in vivo, isolates were first evaluated for their replica-
tion competency in bone marrow/liver/thymus (BLT) mice and T 
cell–only mice (ToM). BLT mice are reconstituted with T cells, B 
cells, and myeloid cells (37, 38), while ToM are devoid of human 
monocytes and B cells but have a full complement of human T cells 
(39). Both BLT mice and ToM have been shown to support HIV rep-
lication and persistent infection as determined by the presence of 
latently infected human T cells (39–41). BLT mice and ToM were 
infected with 8 different viruses: 1 primary HIV-2 isolate (7312A) 
(42, 43); 1 HIV-1 early-passage isolate (JRCSF) (44, 45); 4 HIV-1 
transmitted/founder viruses (THRO, RHPA, CH058, and CH040) 
Figure 3. HIV replication can be sustained over time in human macrophages in vivo, but it is limited to very few HIV strains. (A) Efficient replication of 
all HIV strains tested in BLT mice as determined by viral load analysis. (B) Efficient replication of all HIV strains tested in ToM mice as determined by viral 
load analysis. (C) Plasma viral load of infected MoM. Only HIV-1 ADA, CH040, and CH040-4013 env (a patient envelope–derived chimeric virus) were detect-
able in the plasma over time. (D) Increased numbers of CD14+CD16+ cells (intermediated phenotype monocytes) were detected in the blood of infected 
MoM (n = 17) during the first few weeks of infection compared with the blood of uninfected MoM (n = 11). VL, viral load.
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devoid of T cells did so efficiently, resulting in sustained levels 
of virus replication in the plasma for the duration of the experi-
ment (up to 15 weeks, the last time point evaluated) (Figure 3C). 
HIV infection of NOD/SCID mice transplanted with CD34+ stem 
cells led to transiently increased numbers of intermediate phe-
notype monocytes in the peripheral blood (Figure 3D), similar to 
what is seen in humans (54). Together, the results presented above 
demonstrate that all of the isolates tested can replicate efficiently 
in humanized mice containing human T cells. These results also 
demonstrate that myeloid cells can support in vivo replication 
of only macrophage-tropic viruses (3 of 8 tested, Table 2). How-
ever, the viruses that were capable of replicating in the absence 
of T cells were able to sustain robust levels of infection that were 
maintained for the entire experimental period. Sequencing of the 
V1–V5 region of the viral envelope in MoM infected for 8 to 18 
weeks (n = 3 for CH040 and n = 5 for CH040-4013 env) did not 
reveal changes in the nucleotide sequence of the original infecting 
virus. These results, together with the fact that viral load in plasma 
was readily detectable shortly after exposure, suggest that these 
viruses are able to replicate efficiently in macrophages in vivo 
without the need of further adaptation. In NOD/SCID mice trans-
planted with hCD34+ cells, the only human cells that are suscepti-
ble to HIV infection and that support HIV replication are myeloid 
cells, hence our designation of these mice as MoM.
Systemic replication of macrophage-tropic viruses in MoM in the 
absence of T cells. Having established the replication competence 
of macrophage-tropic viruses in MoM in the complete absence of 
T cells in peripheral blood, we next determined the presence of 
infected cells in tissues. For this purpose, cells from the spleen, 
liver, lung, and bone marrow from infected MoM were analyzed 
for the presence of HIV DNA. Consistent with systemic infection, 
HIV DNA was readily found in all tissues examined (Figure 4A). 
To determine whether systemic viral replication was occurring, 
tissues from MoM were analyzed for the presence of HIV RNA 
(Figure 4B). HIV RNA was readily detected in all tissues analyzed. 
Electron microscopic analysis of the bone marrow from HIV- 
infected MoM showed the presence of viral budding as well as 
free virions in this tissue (Figure 4C). To confirm the identity of 
the infected cells in the liver, lung, and spleen, we used immu-
nohistochemical staining combined with ISH analysis. The pres-
ence of HIV RNA in hCD68-expressing cells in these tissues con-
firmed that the virus detected in the tissues of HIV-infected MoM 
was indeed being produced by human macrophages (Figure 4D). 
Together, these results demonstrate systemic replication of mac-
rophage-tropic viruses in MoM.
To determine the frequency at which replication-competent 
virus exists in the tissues of infected MoM, we performed an in 
vitro outgrowth assay. Cells obtained from different tissues of MoM 
(bone marrow, spleen, liver, and lung) were cocultured ex vivo with 
CD8-depleted, HIV-negative, PHA-activated allogeneic peripheral 
blood mononuclear cells (PBMCs). Culture supernatants were ana-
lyzed by PCR after 10 days for the presence of vRNA. Coculture 
of cells from infected MoM with activated allogeneic CD4+ cells 
resulted in viral outgrowth in the majority of wells from all tissues, 
with as few as 135 total human macrophages leading to infection of 
the cultures (Figure 4E). This demonstrates that infected macro-
phages are found in all tissues, and even a small number of macro-
phages can lead to productive infection of T cells in culture.
Analysis of HIV infection in macrophages in BLT mice. To 
determine whether tissue macrophages were also infected in 
BLT mice, we performed ISH analysis of liver, lung, and spleen 
from a BLT mouse infected with HIV-1 CH040-4013 env using 
RNAscope technology and staining with anti-hCD68. Dual- 
labeled hCD68+ and HIV RNA+ cells were present in the liver, 
lung, and spleen (Supplemental Figure 1A). To facilitate direct 
comparison of the levels of infection of macrophages in BLT mice 
and MoM, we used the cell-sorting method described above for 
the isolation of purified macrophages. Total MNCs were pooled 
from the spleen, liver, lung, and bone marrow of an individual 
BLT mouse or MoM infected with HIV-1 CH040. Mouse and 
human T cells were then depleted using positive magnetic selec-
tion. Human macrophages were further purified using negative 
magnetic selection essentially as indicated above. Total DNA 
was then extracted and analyzed for the presence of HIV DNA 
using quantitative real-time PCR. On average, we found 2,065 
± 346 HIV DNA copies per 100,000 human macrophages iso-
lated from infected BLT mice, and, on average, we found 402 
± 162 HIV DNA copies per 100,000 human macrophages iso-
lated from infected MoM (Supplemental Figure 1B, P = 0.0121). 
Experimental details for this section are found in the Supple-
mental Methods. These results confirm the infection of human 
macrophages in BLT mice. Consistent with the higher viral load 
detected in BLT mice, we also observed a higher infection level 
of macrophages in these mice.
HIV infection is established in the brains of MoM. As indicated 
above, it has been postulated that HIV infection of the CNS is 
established and maintained in human myeloid cells (9, 55). SIV 
infection of macaques leads to accumulation of monocytes and 
macrophages in the CNS (11); therefore, we wanted to deter-
mine the effect of HIV infection on the number of human cells 
Table 2. Viral replication of HIV in various humanized mouse models
JRCSF 7312A (HIV-2) THRO RHPA CH058 ADA CH040 CH040-4013 env
BLT + (n = 6) + (n = 3) + (n = 5) + (n = 2) + (n = 1) + (n = 1) + (n = 7) + (n = 7)
ToM + (n = 9) + (n = 1) + (n = 2) + (n = 2) + (n = 1) + (n = 1) + (n = 4) + (n = 8)
MoM – (n = 4) – (n = 3) – (n = 3) – (n = 3) – (n = 3) + (n = 5) + (n = 21) + (n = 17)
Summary of viruses that were evaluated for replication in MoM, ToM, and BLT mice with regard to plasma viremia and tissue vDNA analysis. For viruses in 
MoM marked with a minus sign, at least 1 animal was evaluated for the presence of vDNA in the spleen, liver, lung, and bone marrow and was determined 
to be uninfected.
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in this tissue. Compared with uninfected controls, the total 
number of human cells and human macrophages in the brains 
of infected animals increased significantly from 1,947 to 4,805 
(P = 0.0009) for total human cells and from 635 to 1,399 for total 
human macrophages (P = 0.0055) (Figure 5A). We also were also 
able to demonstrate by IHC the presence of human macrophages 
(CD68+) throughout the brain, including the cerebellum, caudate 
putamen, cerebral cortex, ventral striatum, and brain stem, of 
HIV-infected MoM (Figure 5B).
Having established that human macrophages are present in 
the brains of infected MoM, we investigated whether HIV infection 
is established in the brains of these animals. Mice were transcar-
dially perfused with PBS at necropsy to minimize contamination 
with blood-derived cells, such as monocytes, as well as purge any 
free virus that might be circulating in the brain. We isolated MNCs 
from the brains of MoM infected with the 3 macrophage-tropic 
viruses (ADA, CH040, and CH040-4013 env) and used HIV RNA 
as a surrogate for HIV replication. vRNA was detected, in cells 
isolated from 8 of 14 infected animals, representing all 3 macro-
phage-tropic isolates (Figure 5C). Immunohistochemical analy-
sis demonstrated the presence of HIV-infected cells (p24+) in the 
brains of infected MoM (Figure 5D). HIV p24+ cells were located in 
the cerebellum, cerebral cortex, corpus callosum, midbrain, brain-
stem, and caudate putamen of infected MoM.
Figure 4. Systemic replication of HIV-1 in the tissues of MoM. (A) Cell-associated vDNA copies per 100,000 total cells and (B) cell-associated vRNA copies 
per 100,000 total cells were measured from cells isolated from bone marrow (BM), spleen, liver, and lung of MoM infected with ADA (n = 2), CH040 (n = 10), 
or CH040-4013 env (n = 9). (C) Electron micrograph of infected MoM bone marrow shows the presence of viral budding (black arrows) as well as free virions 
(green and red arrows) in the tissue. Virions in which the viral core was visible are denoted with red arrows. Original magnification, ×20,000 to ×100,000, 
as indicated in each image. (D) ISH analysis of the tissues of a MoM infected with CH040 demonstrated the presence of human macrophages (expressing 
CD68, brown staining) producing HIV RNA transcripts (black granules). Original magnification, ×100. (E) Cells from infected MoM tissues (bone marrow  
[n = 20], spleen [n = 11], liver [n = 11], and lung [n = 8]) were cultured with allogenic donor CD8–depleted feeder cells. Viral outgrowth was determined by the 
presence (black squares) or absence (white squares) of vRNA in the culture supernatants after 10 days. The number of human macrophages plated in each 
culture is graphed on the y axis. We were able to measure outgrowth in 41 of 50 total samples (All tissues).
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determine whether macrophages in BLT mice are productively 
infected, tissue macrophages were isolated from the spleen, liver, 
lung, and bone marrow of a BLT mouse (infected with CH040). 
T cells were first removed by positive magnetic selection against 
CD3, and myeloid cells were further enriched by negative mag-
netic bead selection, using the methodology outlined above for 
patients’ peripheral blood cells (Figure 1A). Purified myeloid cells 
were then injected i.v. into a MoM. This resulted in sustained virus 
replication in the recipient animal, confirming that macrophages 
Adoptive transfer of HIV-infected macrophages establishes de novo 
infection. To determine whether the infected myeloid cells present 
in MoM could establish de novo infection in an uninfected host, we 
isolated cells from infected MoM and injected them i.v. into unin-
fected animals. First, bone marrow cells from 3 MoM (infected 
with CH040 or CH040-4013 env) were injected into BLT mice. 
This resulted in the development of rapid plasma viremia in all 
recipient animals (a total of 4 BLT mice), confirming the replica-
tion competence of the viruses present in the MoM (Table 3). To 
Figure 5. Human cells are present in the brains of MoM and increase in numbers during HIV infection. (A) MNCs from the brains of infected (n = 25) and 
uninfected (n = 35) MoM were analyzed via flow cytometry, and the absolute numbers of human cells (hCD45+) and human macrophages (hCD33+/hCD11b+) 
were calculated per whole brain. There was a significant increase in the overall number of human cells (P = 0.0009) and human monocytes and macro-
phages (P = 0.0055) in the brains of infected mice compared with numbers detected in uninfected mice. P values were determined by Mann-Whitney U 
test. (B) Immunohistochemical analysis of the brain was used to confirm the presence of human macrophages (hCD68) in the brains of infected MoM. 
(C) Cell-associated vRNA copies per 100,000 total cells were measured in the brains of infected MoM. We were able to detect virus in the brains of 8 of 14 
animals (lower limit of detection, 30 copies/105 cells). (D) Immunohistochemical analysis demonstrated the presence of HIV p24 in the brains of infected 
MoM. (B and D) Original magnification, ×10 and ×40 (insets). The location of CD68+ or p24+ cells is indicated by an abbreviation in each panel. BS, brain 
stem; CB, cerebellum; CC, cerebral cortex; CP, caudate putamen; CpC, corpus callosum; MB, midbrain; and VS, ventral striatum.
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susceptibility to infection was identified as a confounding factor 
(7). We expected ADA, a macrophage-tropic virus, to replicate in 
MoM. However, we did not expect that CH040, being a transmit-
ted/founder virus, would replicate well in MoM (59–61) and were 
surprised to see sustained and systemic replication of this virus in 
MoM. In addition, a chimeric virus in which the envelope gene of 
CH040 was replaced by one obtained from the CNS of a patient 
(12) also replicated well in MoM.
Previous experiments to better understand HIV infection of 
macrophages in vivo have been conducted using SIV infection 
(62). Using rhesus macaques, it has been shown that CD4 deple-
tion (before infection) leads to robust SIV infection of macro-
phages (63, 64). Additionally, infection of macrophages results 
in a constant level of viral production and no post-peak drop in 
viremia (63). In CD8-depleted (after infection) rhesus macaques, 
increased numbers of monocytes and macrophages entered into 
the CNS of SIV-infected animals compared with that seen in unin-
fected animals (11). Similar to the above-cited studies, we noted 
no post-peak drop in viremia and found higher numbers of human 
macrophages in the brains of infected MoM compared with num-
bers in the brains of uninfected MoM. These results can be attrib-
uted to HIV infection of macrophages specifically, as MoM are 
devoid of T cells. HIV replication in MoM could not be ascribed 
to the phagocytosis of T cells by macrophages, and replication 
occurred only in the human myeloid cells present.
Despite the lack of infected monocytes in peripheral blood, 
we found strong evidence of productive macrophage infection 
in tissues. Replication in macrophages was verified by sustained 
plasma viremia, immunohistochemical and ISH analyses, electron 
microscopy, bulk DNA and RNA detection, and in vitro and in vivo 
outgrowth assays. Our data demonstrating that macrophages iso-
lated from BLT mice infected with the macrophage-tropic strains 
are capable of establishing HIV infection when injected into naive 
recipients indicate that macrophages can be productively infected 
with HIV in the absence or presence of human T cells. Given the dif-
ficulties of procuring human tissue samples that invariably will also 
contain T cells, the availability of an in vivo model such as MoM rep-
resents a significant advance in the field. Furthermore, the complete 
present in this infected BLT mouse were productively infected. 
The presence of productively infected macrophages in HIV-in-
fected BLT mice was confirmed by injecting pooled macrophages 
purified from 3 BLT mice (infected with CH040) into a MoM and 
a BLT mouse. The purified macrophages were able to establish de 
novo infection in both of the recipient animals, confirming our ini-
tial observation. These results (Table 3) demonstrate that the virus 
replicating in macrophages of BLT mice and MoM can efficiently 
transmit de novo infection to a new host and replicate in vivo in the 
presence or complete absence of human T cells.
Discussion
The study of HIV and SIV replication in macrophages has been 
confounded, as the presence of viral nucleic acids in these cells 
has been attributed to phagocytosis of infected T cells and cellular 
debris (25, 26). Despite the postulated importance of macrophages 
in HIV infection and AIDS-associated neurological complications, 
infection of monocytes and macrophages in vivo has been ques-
tioned (15–17, 25, 26, 56, 57). Our results using monocytes isolated 
from viremic and aviremic patients are consistent with those 
showing a lack of infection of these cells in humans (15–17). These 
outcomes have been ascribed to differences in the susceptibility 
of monocytes and macrophages to HIV infection during differen-
tiation (56, 58) and highlight the need to study infection of tissue 
macrophages rather than monocytes.
To investigate in vivo HIV infection of macrophages, we took 
advantage of 2 humanized mouse models that we had previously 
developed (ToM and BLT mice) and implemented a new model in 
which only human myeloid cells can serve as targets for HIV infec-
tion (MoM). Only macrophage-tropic viruses (ADA, CH040, and 
CH040-4013 env) were able to sustain infection in the absence of 
human T cells. Since all isolates tested utilize CCR5 as a corecep-
tor (46, 48, 49), the ability of these viruses to productively infect 
MoM is likely related to an ability to infect cells expressing low lev-
els of CD4 on their cell surface (12, 14). It should be noted that the 
HIV-infected MoM in this study represent animals reconstituted 
with cells from 24 different human donors; this contrasts with the 
findings of an in vitro study of MDMs, in which donor variation in 
Table 3. Human macrophages can establish de novo infection of humanized mice
Donor mouse/mice Virus Cell type used No. of cells injected No. of HIV DNA+ cells injected Recipient mouse Evaluation of infection
Plasma VL Tissue vDNA
MoM #1 CH040 Bone marrow cells 4.00E+06 15,880 BLT #1 + +
MoM #2 CH040-4013 env Bone marrow cells 4.00E+06 11,520 BLT #2 + +
MoM #3 CH040 Bone marrow cells 2.00E+06 1,820 BLT #3 + ND
BLT #4 + ND
BLT #5 CH040 Purified macrophages 3.80E+05 148 MoM #4 + +
BLT #6, 7 and 8 CH040 Purified macrophages 4.00E+06 4,760 BLT #9 + +
MoM #5 + +
MNCs were isolated from the bone marrow of infected MoM and injected into humanized BLT mice, resulting in systemic infection of the BLT mice. Total 
MNCs were harvested from the liver, lung, spleen, and bone marrow of BLT mice infected with CH040. Two sequential steps purified tissue macrophages: 
(1) positive magnetic selection was used to deplete T cells; and (2) negative magnetic selection was used to further purify the pool of human macrophages. 
Macrophages from infected BLT mice were analyzed for vDNA levels and were then injected into MoM. MoM and BLT mice were evaluated at necropsy for 
HIV infection over time in the blood and in tissues. Results indicated by a plus sign are samples that tested positive for HIV-1 RNA (plasma viral load) or 
DNA (for tissue cells). ND, not determined.
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Generation of humanized mice. Humanized ToM and BLT mice 
were prepared by implanting allogeneic thymus and liver tissue into 6- 
to 8-week-old NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice (NSG; The Jack-
son Laboratory) as previously described (39, 41, 51–53). Implants con-
sisted of a 1- to 2-mm piece of fetal liver tissue sandwiched between 2 
pieces of fetal thymus. Each implant was seated under the left kidney 
capsule. In addition to the thymus/liver/thymus implant, BLT mice 
also received autologous CD34+ hematopoietic stem cells (CD34 
Microbead Kit, catalog 130-046-703; Miltenyi Biotec). Humanized 
MoM were prepared by transplanting approximately 1 × 106 human 
fetal liver or cord blood–derived CD34+ hematopoietic stem cells into 
NOD.CB17-Prkdcscid/J mice (NOD/SCID; The Jackson Laboratory). 
Prior to humanization, all mice were preconditioned using gamma 
radiation with 2 Gy (ToM and BLT mice) or 2.5 Gy (MoM).
Flow cytometric analysis of patients’ cells and humanized mice. All 
flow Abs were purchased from BD Pharmingen. The Ab panel used to 
analyze cells isolated from HIV-infected patients included Abs directed 
against hCD45 (APC, catalog 555485); hCD3 (FITC, catalog 555339); 
hCD4 (APC-H7, catalog 560158); hCD8 (PerCP, catalog 347314); 
hCD19 (PE-Cy7, catalog 557835); and hCD11b (PE, catalog 555388). In 
all samples, less than 0.1% of T cells were present in the purified mono-
cyte population. To monitor humanization levels in humanized mice, 
peripheral blood was obtained from animals via submandibular veni-
puncture and collected into tubes containing EDTA. Whole peripheral 
blood was stained with the Ab panel listed above, with the exception 
that an Ab directed against hCD33 (PE, catalog 340679) was substi-
tuted for the anti-hCD11b Ab. For tissue and blood analysis from har-
vested mice, combinations of the above Abs were used. Additionally, 
Abs directed against hCD14 (FITC, catalog 555397); hCD16 (PE-Cy7, 
catalog 557744); hCD11b (APC, catalog 340937); hCD45 (APC-Cy7, 
catalog 557833); and HLA-DR (PerCP, catalog 347364) were used for 
the animals depicted in Figure 2, D and E. Live cells were distinguished 
by their forward- and side-scatter profiles as previously described (50). 
Flow cytometric data were collected on a BD FACSCanto and analyzed 
with BD FACSDiva software, version 6.1.3.
Tissue harvesting of humanized mice. To prevent blood contami-
nation of tissues (in particular, brain tissues), mice were transcardi-
ally perfused with approximately 20 ml room-temperature PBS at 
necropsy. MNCs were isolated from the bone marrow, spleen, lung, 
and liver of MoM or BLT mice as previously described for ToM and 
BLT mice (39, 71, 72). Tissues were minced and/or digested and fil-
tered through a 70-μm strainer. The liver, lung, and brain MNCs were 
purified with Percoll density centrifugation. MNCs were washed and 
counted via trypan blue exclusion, and flow cytometric analyses were 
performed for the indicated markers.
HIV-1 infections. Stocks of HIV-1 (JRCSF, RHPA, THRO, ADA, 
CH058, CH040, and CH040-4013 env) and HIV-2 (7312A) were 
prepared and titered as previously described (73). Briefly, viral super-
natants were prepared via transient transfection of 293T cells and 
were tittered using TZM-bl cells (an indicator cell line) as previously 
described (74). The chimeric virus CH040-4013 env was created by 
replacing env in CH040 (GenBank database accession no. jn944905, 
6396-8863) with the corresponding restriction fragment from subject 
4013 (GenBank database accession no. jn562796). Subject 4013 had 
mild neurological dysfunction (12). To test various HIV strains for mac-
rophage tropism, 360,000 tissue culture infectious units (TCIU) of 
virus was injected i.v. into MoM. BLT mice and ToM were exposed i.v. to 
lack of human T cells in our MoM model dispels the notion that the 
presence of HIV nucleic acids in macrophages is due to phagocytosis 
of infected T cells; rather, it confirms that macrophages can sustain 
infection in vivo, which is dependent on specific HIV isolates that 
can replicate in macrophages like those used in our study.
Monocyte and macrophage transmigration into the brain has 
been considered to play a central role in establishing HIV infection 
of the CNS (65). ART has resulted in significant overall benefits 
to HIV-infected patients, but does not always result in neuropsy-
chological improvements (66–68), and this may stem from differ-
ences in the tropism of viruses found in the periphery compared 
with that seen in the CNS (9, 55, 69, 70). Here, we demonstrate 
that T cells are not necessary to traffic the virus from the periph-
ery to the brain and that macrophages can sustain infection of the 
CNS. However, several issues remain to be addressed in future 
work. Given our analysis, we cannot ascertain whether the appear-
ance of HIV+ cells in the CNS represents de novo infection or the 
migration of infected cells from other tissues into the brain. If it 
represents de novo infection, it will be important to determine 
whether the appearance of these HIV+ cells is initiated via cell-free 
or cell-associated virus. The number of infected myeloid cells in 
the periphery of MoM was very low compared with the relatively 
high viral load detected in these mice, suggesting that cell-free 
virus was seeding the infection in the brain of MoM. Our results 
demonstrating the lack of HIV infection of blood monocytes from 
humans suggest that infected monocytes might not be directly 
responsible for the seeding of HIV in the CNS of humans, but 
rather that cell-free virus or infected T cells in peripheral blood are 
responsible for introducing HIV into the CNS.
We believe our studies have significant implications for the field. 
They establish tissue macrophages as true targets of productive HIV 
infection. Our results imply that tissue macrophages might serve 
as a reservoir for latent HIV infection in patients, as these cells are 
capable of sustaining infection over long periods of time. The fact 
that no infected monocytes were present (or were present at very 
low levels) in the peripheral blood of patients suggests that future 
analysis of HIV latency in myeloid cells in humans will be compli-
cated by the need to directly sample tissues in sufficient amounts 
to perform persistence, latency, and induction analyses. MoM could 
be used to directly assess the role of tissue-derived macrophages in 
the persistence of HIV infection in vivo during ART, and this will 
represent an important future direction for this model. Specifically, 
MoM could be used to address the effectiveness of ART to control 
viral replication in macrophages. Overall, this model is a unique tool 
to better understand HIV replication in macrophages in vivo.
Methods
Patient blood cell isolations. Approximately 8 ml blood was obtained 
from deidentified viremic and ART-suppressed patients and separated 
into 8 sodium citrate CPT tubes (64 ml total; catalog 362761; BD). Sam-
ples were spun down, and plasma was isolated from each tube for viral 
load analysis. MNCs were then collected and washed in PBS. Positive 
magnetic selection for CD3+ T cells (CD3 MicroBeads, catalog 130-
050-101; Miltenyi Biotec) was performed. Next, negative magnetic 
selection for monocytes (Pan Monocyte Isolation Kit, catalog 130-096-
537; Miltenyi Biotec) was performed on the non-CD3 cell population to 
yield a monocyte population that was more than 90% pure.
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Electron microscopic analysis of MoM bone marrow. Femurs from 
CH040-infected MoM were harvested and immersed in fixative con-
taining 4% paraformaldehyde, 2.5% glutaraldehyde (in 0.1 M sodium 
cacodylate buffer [pH 7.4] with 5 mM calcium chloride), and 1 mM 
magnesium chloride for several days at 4°C. Femurs were decalcified 
with a solution of 0.1 M EDTA in 0.1 M sodium cacodylate (pH 7.4) 
containing 1% glutaraldehyde for 2 weeks at 4°C. After buffer washes, 
the tissues were post-fixed with 1% osmium tetroxide in 0.1 M sodium 
cacodylate (pH 7.4) for 1 hour at room temperature and gradually 
dehydrated with ethanol and propylene oxide, followed by infiltra-
tion and embedment in PolyBed 812 epoxy resin (Polysciences Inc.). 
Ultrathin sections (70-nm) were post-stained with uranyl acetate and 
lead citrate and observed using a LEO EM910 transmission electron 
microscope operating at 80 kV (Carl Zeiss SMT). Digital images were 
taken using an Orius SC1000 CCD camera and Digital Micrograph 
software, version 2.3.1 (Gatan Inc.).
Immunohistochemical analysis of MoM brains. Brains for immu-
nohistochemical analysis were harvested from MoM and fixed in 4% 
paraformaldehyde for 24 hours at 4°C, embedded in paraffin, cut into 
5-μm sections, and mounted onto poly-L-lysine–coated glass slides. 
Following paraffin removal, antigen retrieval (DIVA Decloaker, cata-
log DV2004; Biocare Medical), and blocking of nonspecific Ig-bind-
ing sites (Background Sniper; Biocare Medical), tissue sections were 
stained with primary Abs overnight at 4°C and developed with a biotin-
free HRP polymer system (MACH3 Mouse HRP-Polymer Detection; 
Biocare Medical). All tissue sections were then counterstained with 
hematoxylin. Primary Abs directed against CD45 LCA (clone 2B11 + 
PD7/26; Dako) and CD68 (clone KP1; Dako) were used to determine 
the presence of human cells and human macrophages in the brains of 
MoM. HIV-infected cells were detected with an Ab directed against 
HIV p24 gag (clone Kal-1; Dako). As a control, tissue sections were 
stained with a mouse IgG1k isotype control (DAK-GO1; Dako). Light 
microscopic images were taken with a Nikon H550S microscope at 
×10 magnification (×40 magnification for inset images).
ISH analysis. Double-label ISH was performed as previously 
reported (27), with minor modifications. In brief, formalin-fixed, 
paraffin-embedded tissue sections were deparaffinized in xylene, 
treated with hydrogen peroxide in ethanol, pretreated with digitonin 
and proteinase K, acetylated with acetic anhydride, and dehydrated. 
After hybridization with HIV 35S riboprobe mixture containing aurin 
tricarboxylic acid, and after hybridization washes, antigens were 
retrieved in 10 mM citrate (pH 6), and 0.1 M KCl at 65°C for 4 hours. 
After blocking, incubation with primary CD68 Ab overnight at 4°C, 
and incubation with secondary Ab coupled with peroxidase, CD68+ 
cells were stained with DAB. Nuclei were stained with hematoxylin, 
and the sections were dehydrated and cleared with xylene and cover-
slipped with Permount. Light microscopic images were taken with an 
Olympus BX60 microscope at ×20 magnification.
Adoptive transfer experiments. Infected MoM or BLT mice were 
harvested and processed as described above. For the first 2 adoptive 
transfer experiments, bone marrow cells from 2 separate infected 
MoM were injected i.v. into 2 separate BLT mice. In the third transfer 
experiment, macrophages were purified from an infected BLT mouse 
using the magnetic isolation strategy described above for patients’ 
cells and injected i.v. into a MoM. For the last 2 adoptive transfer 
experiments, macrophages were purified from the pooled cells of 3 
infected BLT mice and injected i.v. into a MoM and a BLT mouse. For 
360,000 TCIU ADA, CH040, or CH040-4013 env. For the non–mac-
rophage-tropic isolates (RHPA, THRO, JRCSF, HIV-2, and CH058), 
ToM or BLT mice were exposed i.v. or vaginally to 90,000 to 360,000 
TCIU of the various viruses to confirm replication competence.
Analysis of HIV-1 infection. Subsequent HIV DNA analysis of 
patients’ cells and of cells isolated from BLT mice that received 
patients’ cells was performed using nested PCR analysis for HIV-gag. 
For all patient-derived blood cells, 1 × 106 cells were analyzed. For 
humanized mouse samples, 1 × 105 to 3 × 106 cells were analyzed, 
depending on the cell yield from the various tissues. Genomic DNA 
from MNCs (5 × 105 to 5 × 106 MNCs) from animal tissues was prepared 
using QIAamp DNA Blood Mini columns (QIAGEN) according to the 
manufacturer’s protocol. Viral DNA was amplified by nested PCR 
using the Expand High Fidelity PCR System (Roche). The HIV region 
amplified was a 1.5-kb region in gag (gag: HIV-1JRCSF 617–2358). 
Amplification of gag was used to assess the presence or absence of 
HIV-1 gag DNA. Primer sequences were as follows: gag outer forward 
primer, CTCAATAAAGCTTGCCTTGAGTGC; gag outer reverse 
primer, CTTCCAATTATGTTGACAGGTGTAGG; gag inner forward 
primer, GTGTGGAAAATCTCTAGCAGTGGC; and gag inner reverse 
primer, TAGAAGAGAAGGCTTTCAGCC. Peripheral blood (approx-
imately 100 μl total) was collected from mice via retro-orbital bleed-
ing using EDTA-coated capillary tubes. Infection of MoM with HIV-1 
isolates was determined with a 1-step reverse transcriptase real-time 
PCR assay (TaqMan Assays-by-Design, custom-designed by Applied 
Biosystems) according to the manufacturer’s instructions (with prim-
ers 5′-CATGTTTTCAGCATTATCAGAAGGA-3′ and 5′-TGCTTGAT-
GTCCCCCCACT-3′; assay sensitivity of ~668 RNA copies/ml). Addi-
tionally, at necropsy, MNCs were isolated from tissues and analyzed 
for the presence of vRNA and vDNA. For viral coculture analysis, 
human macrophages were plated and allowed to adhere. Within 24 
hours of plating, approximately 1 million allogenic, PHA-stimulated 
feeder cells (CD8-depleted) from healthy donors were added to the 
cultures as targets for viral outgrowth. After 10 days, culture superna-
tants were analyzed for the presence of vRNA.
Sequencing of HIV-1 in MoM plasma. For sequence analysis of HIV-1 
envelope, vRNA was isolated from plasma obtained from infected 
MoM using the QIAamp Viral RNA Mini Kit (QIAGEN). Viral cDNA 
was generated using Superscript III Reverse Transcriptase (Invitro-
gen) and amplified by nested PCR using the Expand High Fidelity PCR 
System. The amplified region was a 1.2-kb region including the V1–V5 
regions of the viral envelope (CH040 6426-7702; CH040-4013 6426-
7702). The primers used for CH040 env amplification included env 
outer forward primer, CACCACTCTATTTTGTGCATCAGATG; env 
outer reverse primer, GCCCATAGTGCTTCCTGCTGC; env inner 
forward primer, CACACATGCCTGTGTACCCACAGAC; and env 
inner reverse primer, CTCTTCTCTTTGCCTTGGTAGGTGC. The 
primers used for CH040-4013 env amplification included env outer 
forward primer, CACCACTCTATTTTGTGCATCAGATG; env outer 
reverse primer, GCCCATAGTGCTTCCTGCTGC; env inner for-
ward primer, CACACATGCCTGTGTACCCACAGAC; and env inner 
reverse primer, CTCTTCTCTTTGCCTTGGTGGGTGC. Amplified 
DNA was sequenced and aligned to HIV-1 CH040 or CH040-4013 
env to determine whether nucleotide changes had occurred. FinchTV 
(Geospiza) was used for the sequence analysis of the chromatograms. 
We used ClustalW (http://www.genome.jp/tools/clustalw/) for align-
ment of the MoM envelopes to the reference sequences.
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